United States:
Federal Circuit's En Banc Review in Aqua Products Could Upend PTAB Amendment Practice
14 December 2016
Arnold & Porter
To print this article, all you need is to be registered or login on Mondaq.com.
Originally appeared in
PTAB Monitor: Developments in Inter Partes Review Practice
Originally published in IP Watchdog on December 4,
2016.
On December 9, 2016, the en banc Federal Circuit will hear
argument in In re Aqua Products, Inc. on an issue that has
long been troubling patent owners involved in inter partes reviews
(IPR)—the difficulty of amending patent claims before the
Patent Trial and Appeal Board (PTAB).
» Read the remainder of the article on
IP Watchdog.
» Read more articles from our latest report, PTAB
Monitor: Developments in Inter Partes Review
Practice.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Intellectual Property from United States
"Patent Marking Regarding Software Medical Devices"
Marshall, Gerstein & Borun LLP
The IPO Law Journal recently published a paper titled "Patent Marking Regarding Software Medical Devices." The paper discusses an overview of patent marking-related case law...